One in three Australian men and one in four women are directly affected by cancer before the age of 75 and over 100,000 new cases are diagnosed every year. While survival rates have increased significantly over the past 20 years, cancer remains a leading cause of death: while more than half of the diagnosed cases are successfully treated, every year over 36,000 Australians die of the disease.
Cancer costs the health system over $2.7 billion per year, and its cost in terms of pain and suffering is inestimable. The only way to change these statistics is with high-quality prevention, early detection and new treatments: our best chance of achieving these goals is with basic medical research.
Cancer is a complex and varied disease, which is why, at SVI, we approach it from different angles. The Stem Cell Regulation group investigates stem cells and their role in cancers of the blood. In the Cancer and RNA Biology Laboratory, Carl Walkley's work is focused on understanding the regulation of RNA and how this is important in normal development and in cancer. In Molecular Genetics, Jörg Heierhorst’s group is working on understanding how the DNA damage that underlies most cancers develops while Andrew Deans in Genome Stability works to understand the mechanisms cells use to protect themselves from cancer-causing mutations. Researchers in SVI's O'Brien Institute Department are focused on diseases of cancer survivorship.
Learn more about cancer:
Community Cancer Fact Sheet
Fanconi Anaemia Meeting 2017 - Speaker presentations
Dr Andrew Deans, SVI - What is the cause of Fanconi Anaemia?
Dr Chris Fraser, BMTs for FA
Dr Jordi Surralles, new genes new therapies
Lisette Curnow, Genetic counselling and FA
Shuhying Tan, Haematology 101